MTDMettler Toledo
Is the business good?
The checks split: nothing decisive, though elite returns on assets.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
High-quality, exceptional returns on the assets themselves, not leverage. ROE 240% = margin × turnover × leverage.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is MTD?
Mettler Toledo keeps 22% of every revenue dollar as profit after everything, against 3.6% for the median Diagnostics & Research name.
Net margin · Diagnostics & Research median 3.6% · 12 months to Q2 2026
- Share count, year on year
- −2.8%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 5.0%
R&D as % of revenue
- Gross margin
- 60%
Gross margin
Details›
- Gross margin12 months to Q2 2026
- 60%
- Net margin12 months to Q2 2026
- 22%
- Free cash flow margin
- 21%
- R&D as % of revenue
- 5.0%
- Revenue, trailing twelve months
- $4.13B
- Free cash flow, trailing twelve months
- $864M
- Net income, trailing twelve months
- $906M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Diagnostics & Research
The closest names by size in the same industry